Lite Strategy Stock Today

LITS Stock   1.54  0.22  16.67%   

Performance

Weakest

 
Weak
 
Strong

Odds Of Distress

Risky

 
High
 
Low
Lite Strategy is selling for under 1.54 as of the 4th of January 2026; that is 16.67% up since the beginning of the trading day. The stock's lowest day price was 1.4. Lite Strategy has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Lite Strategy symbol was changed from MEIP on 11th of September 2025. The performance scores are derived for the period starting the 5th of December 2025 and ending today, the 4th of January 2026. Click here to learn more.
IPO Date
18th of December 2003
Category
Healthcare
Lite Strategy is entity of United States. It is traded as Stock on NASDAQ exchange. More on Lite Strategy

Moving together with Lite Stock

  0.61NVO Novo Nordisk ASPairCorr

Moving against Lite Stock

  0.88DGWPF Drgerwerk AGPairCorr
  0.82VRTX Vertex PharmaceuticalsPairCorr
  0.77REGN Regeneron PharmaceuticalsPairCorr
  0.77PPERY Bank Mandiri PerseroPairCorr
  0.76PTAIY Astra International TbkPairCorr
  0.67TLK Telkom Indonesia TbkPairCorr

Lite Stock Highlights

Older SymbolMEIP
CFO, CEOJustin CPA
Business ConcentrationBiotechnology, Healthcare, NASDAQ Composite, NASDAQ Health Care, Biotechnology, Healthcare (View all Sectors)
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover1.491.42
Sufficiently Up
Slightly volatile
Gross Profit Margin0.770.86
Moderately Down
Slightly volatile
Total Current Liabilities1.2 M1.2 M
Notably Down
Slightly volatile
Total Assets15.6 M16.5 M
Notably Down
Slightly volatile
Total Current Assets15.6 M16.5 M
Notably Down
Slightly volatile
Debt Levels
Lite Strategy can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Lite Strategy's financial leverage. It provides some insight into what part of Lite Strategy's total assets is financed by creditors.
Liquidity
Lite Strategy currently holds 1.35 M in liabilities. Note, when we think about Lite Strategy's use of debt, we should always consider it together with its cash and equity.

Other Non Cash Items

(328,440)
Lite Strategy (LITS) is traded on NASDAQ Exchange in USA and employs 4 people. Lite Strategy was previously known as MEIP Old and was traded on NASDAQ Exchange under the symbol MEIP. The company conducts business under Healthcare sector and is part of Biotechnology industry. Lite Strategy generates negative cash flow from operations
Check Lite Strategy Probability Of Bankruptcy

Lite Strategy Historical Income Statement

At this time, Lite Strategy's Net Interest Income is comparatively stable compared to the past year. Interest Income is likely to gain to about 1.9 M in 2026, whereas Total Revenue is likely to drop 0.00 in 2026. View More Fundamentals

Lite Stock Against Markets

Additional Tools for Lite Stock Analysis

When running Lite Strategy's price analysis, check to measure Lite Strategy's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lite Strategy is operating at the current time. Most of Lite Strategy's value examination focuses on studying past and present price action to predict the probability of Lite Strategy's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lite Strategy's price. Additionally, you may evaluate how the addition of Lite Strategy to your portfolios can decrease your overall portfolio volatility.